25 results for “Alzheimer's research & therapy”. Showing 25 of 39,449.
Promoting Alzheimer's disease research and therapy with stem cell technology.
Alzheimer's disease (AD) is a prevalent form of dementia leading to memory loss, reduced cognitive and linguistic abilities, and decreased self-care. Current AD treatments aim to relieve symptoms
Updates in Alzheimer's disease: from basic research to diagnosis and therapies.
Alzheimer's disease (AD) is the most common neurodegenerative disorder, characterized pathologically by extracellular deposition of β-amyloid (Aβ) into senile plaques and intracellular accumulation of hyperphosphorylated tau (pTau
Updates in Alzheimer's disease: from basic research to diagnosis and therapies.
Alzheimer's disease (AD) is the most common neurodegenerative disorder, characterized pathologically by extracellular deposition of β-amyloid (Aβ) into senile plaques and intracellular accumulation of hyperphosphorylated tau (pTau
Therapeutic news in Alzheimer's disease: Soon a disease-modifying therapy?
Research on disease-modifying treatments for Alzheimer's disease has resulted in a series of failures over the past 20 years. However, in the last three years, four molecules have
The evolving landscape of Alzheimer's disease therapy: From Aβ to tau.
Alzheimer's disease (AD) therapy research is ongoing. In this
Plasma p-tau217 and p-tau217/Aβ1-42 are effective biomarkers for identifying CSF- and PET imaging-diagnosed Alzheimer's disease: Insights for research and clinical practice.
therapies for Alzheimer's disease (AD), validating plasma biomarkers against cerebrospinal fluid (CSF) and positron emission tomography (PET) standards is crucial in both research
Maximizing the benefit and managing the risk of anti-amyloid monoclonal antibody therapy for Alzheimer's disease: Strategies and research directions.
Anti-amyloid monoclonal antibodies (MABs) have introduced a new era
Proposed Therapeutic Strategy to Combat Alzheimer's Disease by Targeting Beta and Gamma Secretases.
research and clinical testing to improve existing treatments and develop new, efficient Alzheimer's disease therapies
Gut-Brain Axis and a Systematic Approach to Alzheimer’s Disease Therapies
Alzheimer’s disease (AD) is a critical issue that affects both the quality of life of families and public health. Despite years of research, single-target therapies
Effect of the Raga Ananda Bhairavi in Post Operative Pain Relief Management.
research with a clinical approach involving science and art. Music therapy has been used for various therapeutic reasons like Alzheimer
Connexin43 hemichannel blockade turns microglia neuroprotective and mitigates cognitive deficits in a mouse model of amyloidosis.
Research, Shenzhen, China. yichj@mail.sysu.edu.cn. Alzheimer's disease (AD), the leading cause of senile dementia, lacks effective therapies
Unlocking Alzheimer's Disease: The Role of BDNF Signaling in Neuropathology and Treatment.
therapies as a promising avenue for mitigating the cognitive decline associated with Alzheimer's disease, signaling a hopeful direction for future research
A systematic review of the efficacy and safety of anti-amyloid beta monoclonal antibodies in treatment of Alzheimer's disease.
therapies. Further research is needed, highlighting the necessity of AD therapeutic research to alter AD's trajectory and provide reliable treatment. www.crd.york.ac.uk/prospero identifier is CRD42024504358. This study investigates
Comparative effects of some pharmacological and non-pharmacological interventions on cognitive function in Alzheimer's disease: A Bayesian network meta-analysis.
therapy showed no statistical difference from the control group. In addition, the research developed an innovative approach to contrast pharmacological and non-pharmacological treatments for Alzheimer
Alzheimer's disease.
therapy will be combined with lifestyle interventions targeting general brain health to jointly combat the disease. In this Seminar, we discuss the main developments in Alzheimer's research
Tau biology, biomarkers, and therapeutics.
Alzheimer's Association Research Roundtable convened experts from academia, industry, National Institutes of Health (NIH), and the United States Food and Drug Administration (FDA) to explore current progress and future
Charting the research frontier for viral infections, immunomodulation, and dementia: a perspective on synaptic biomarkers as essential clinical trial endpoints.
Alzheimer's disease offers a new paradigm, yet interventions like antivirals and vaccination present a paradox that challenge therapeutic development. This perspective examines the critical research gap concerning cerebrospinal fluid
The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint.
Alzheimer's Disease Consortium Executive Committee, we call for pricing policies that allow eligible patients across Europe to access important innovations, but also continued investments in research and development. Infrastructure
Innovative Interventions: Postbiotics and Psychobiotics in Neurodegenerative Disease Treatment.
Alzheimer's disease, and Parkinson's disease, create more challenges as the population gets older and there are no curative therapies available. Recent advances in gut microbiome research
Genetics and Neuropathology of Neurodegenerative Dementias.
Alzheimer disease and related dementias. In recent years, there has been substantial progress in genetic research, contributing significant knowledge to our understanding of the molecular risk factors involved in neurodegenerative
Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease.
Alzheimer's Disease, Huntington's Disease, and Parkinson's Disease. A mechanistic understanding of ubiquitin-independent proteasome function and regulation in neurodegeneration is critical for the development of therapies
Therapeutic Applications of Natural Flavonoids Against Alzheimer's Disease-like Pathology: Special Focus on PI3K/Akt and Nrf2 Signaling Pathways.
Alzheimer's disease (AD). Due to its complex pathophysiology, currently approved therapeutic agents only provide symptomatic relief and are often associated with serious side effects. Researchers have increasingly focused
Review of PINK1-Parkin-mediated mitochondrial autophagy in Alzheimer's disease.
Alzheimer's disease (AD) is a classical example of neurodegenerative disease. Research on the pathogenesis and treatments of AD has been a focus of scientific research because of its complexity
CRISPR/Cas9 Gene Editing: A Novel Approach Towards Alzheimer's Disease Treatment.
therapy has been difficult. A neurological ailment that progresses and cannot be reversed is Alzheimer's disease, which shows neurofibrillary tangles, beta-amyloid plaque, and a lack of cognitive processes
Ventral Telencephalic Patterning Protocols for Induced Pluripotent Stem Cells.
therapies is a key research agenda and offers the possibility to obtain patient-specific cells of interest for a wide range of diseases. Basal forebrain cholinergic neurons (BFCNs) play